Literature DB >> 12627392

Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding.

Mikhail Matrosovich1, Hans-Dieter Klenk.   

Abstract

Influenza viruses attach to susceptible cells via multivalent interactions of their haemagglutinins with sialyloligosaccharide moieties of cellular glycoconjugates. Soluble macromolecules containing sialic acid from animal sera and mucosal fluids can act as decoy receptors and competitively inhibit virus-mediated haemagglutination and infection. Although a role for these natural inhibitors in the innate anti-influenza immunity is still not clear, studies are in progress on the design of synthetic sialic acid-containing inhibitors of receptor binding which could be used as anti-influenza drugs. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627392     DOI: 10.1002/rmv.372

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  60 in total

1.  Infection of human airway epithelium by human and avian strains of influenza a virus.

Authors:  Catherine I Thompson; Wendy S Barclay; Maria C Zambon; Raymond J Pickles
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 2.  The sweet spot: defining virus-sialic acid interactions.

Authors:  Jennifer E Stencel-Baerenwald; Kerstin Reiss; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  Nat Rev Microbiol       Date:  2014-09-29       Impact factor: 60.633

3.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

Review 4.  Glycomaterials for probing host-pathogen interactions and the immune response.

Authors:  Mia L Huang; Christopher J Fisher; Kamil Godula
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

5.  The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling.

Authors:  Yoshinori Fujimura; Masaharu Takeda; Hidenori Ikai; Ken Haruma; Takeshi Akisada; Tamotsu Harada; Tatsuya Sakai; Masanobu Ohuchi
Journal:  Virchows Arch       Date:  2003-10-10       Impact factor: 4.064

6.  Receptor binding by a ferret-transmissible H5 avian influenza virus.

Authors:  Xiaoli Xiong; Peter J Coombs; Stephen R Martin; Junfeng Liu; Haixia Xiao; John W McCauley; Kathrin Locher; Philip A Walker; Patrick J Collins; Yoshihiro Kawaoka; John J Skehel; Steven J Gamblin
Journal:  Nature       Date:  2013-04-24       Impact factor: 49.962

7.  Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus.

Authors:  Surender Khurana; Swati Verma; Nitin Verma; Corey J Crevar; Donald M Carter; Jody Manischewitz; Lisa R King; Ted M Ross; Hana Golding
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

8.  Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).

Authors:  Bin Su; Sébastien Wurtzer; Marie-Anne Rameix-Welti; Dominic Dwyer; Sylvie van der Werf; Nadia Naffakh; François Clavel; Béatrice Labrosse
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

9.  Comparative pathogenesis of an avian H5N2 and a swine H1N1 influenza virus in pigs.

Authors:  Annebel De Vleeschauwer; Kalina Atanasova; Steven Van Borm; Thierry van den Berg; Thomas Bruun Rasmussen; Ase Uttenthal; Kristien Van Reeth
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

10.  Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.

Authors:  Nongluk Sriwilaijaroen; Prapon Wilairat; Hiroaki Hiramatsu; Tadanobu Takahashi; Takashi Suzuki; Morihiro Ito; Yasuhiko Ito; Masato Tashiro; Yasuo Suzuki
Journal:  Virol J       Date:  2009-08-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.